-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
efgartigimod
-
Medscape: FDA Approves New Myasthenia Gravis Drug
The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody... Full text at...- ME/CFS Science Blog
- Thread
- antibodies argenx drug trial drugs efgartigimod fda igg myasthenia gravis vygart
- Replies: 3
- Forum: Other health news and research